Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Oxycodone 5mg / Naloxone 2.5mg modified-release tablets |
| BNF code | 0407020AFAAACAC |
| Virtual Therapeutic Moiety | Oxycodone + Naloxone |
| Basis of preferred name | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Oxycodone hydrochloride |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 5.000 |
| Strength value numerator unit | mg |
| Virtual Product Ingredient | |
| Ingredient | Naloxone hydrochloride |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 2.500 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tabletmodified-release.oral |
| Dose Form | |
| Formulation | Modified-release tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | Schedule 2 (CD) |
| Actual Medicinal Products | |
| Myloxifin 5mg/2.5mg modified-release tablets (Zentiva Pharma UK Ltd) | |
| Targinact 5mg/2.5mg modified-release tablets (CST Pharma Ltd) | |
| Targinact 5mg/2.5mg modified-release tablets (Napp Pharmaceuticals Ltd) | |
| Targinact 5mg/2.5mg modified-release tablets (Pilsco Ltd) | |
| Virtual Medicinal Product Packs | |
| Oxycodone 5mg / Naloxone 2.5mg modified-release tablets 28 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.